Products

What will AGI do for Betamethasone valerate?

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H37FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9IFA5XM7R2, chemically known as 16-beta-methyl-1,4-pregnadiene-9-alpha-fluoro-11-beta,17-alpha,21-triol-3,20-dione but more generally known as betamethasone valerate, which bears US NIH Compound Identifier 9782. The base compound, Betamethasone, comes in many other forms, including base, acetate, acetate phosphate, acibutate, alcohol, benzoate, butyrate propionate, dihydrogen phosphate, dipropionate, disodium phosphate, phosphate, sodium, sodium phosphate, 17-acetate, 17 alpha-monopropionate, 17-benzoate, 17-dipropionate, 17-propionate, 17-propionate 21-methoxide, 17-valerate, 21-acetate, 21-disodium phosphate, 21-pentanoate, 21-phosphate, and 21-phosphate disodium. European Medicines Agency schedules Betamethasone valerate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00786MIG. Most nations, for tariff and trade purposes, schedule betamethasone valerate under HS 29372200 and SITC 54153. As of Q4 2014, BETAMETHASONE VALERATE remains US FDA's Preferred Term for this commodity. Betamethasone valerate bears US NLM identifiers UMLS ID C0750848 and NCI Concept Code C47962. SMILES: CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO.